Evidence map›Paper›PMID 40575325›Full record

ArticleJACS Au2025

Broad PFAS Binding with Fatty Acid Binding Protein 4 Is Enabled by Variable Binding Modes.

Aaron S Birchfield, Faik N Musayev, Abdul J Castillo, George Zorn, Brian Fuglestad

Abstract read
In one paragraph

Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Aaron S BirchfieldDepartment of Chemistry, Virginia Commonwealth University, Richmond, Virginia 23284, United States.ORCID https://orcid.org/0000-0001-9402-7615
Faik N MusayevDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298, United States.
Abdul J CastilloDepartment of Chemistry, Virginia Commonwealth University, Richmond, Virginia 23284, United States.
George ZornDepartment of Chemistry, Virginia Commonwealth University, Richmond, Virginia 23284, United States.
Brian FuglestadDepartment of Chemistry, Virginia Commonwealth University, Richmond, Virginia 23284, United States.ORCID https://orcid.org/0000-0001-8304-8269

Funding

Peripheral membrane proteins and disease: tool development, basic investigations, and inhibitor designR35GM147221 · NIGMS · WISTAR INSTITUTE · PI Brian Fuglestad · 2022 to 2026
$2.1M
X-ray Crystallographic Data Collection SystemS10OD021756 · OD · VIRGINIA COMMONWEALTH UNIVERSITY · PI SAFO, MARTIN K · 2017 to 2017
$600k
NIGMS NIH HHS R35 GM147221NIH HHS S10 OD021756
6 · The paper itself

Abstract

Per- and polyfluoroalkyl substances (PFAS) are ubiquitous pollutants that bioaccumulate in wildlife and humans, yet the molecular basis of their protein interactions remains poorly understood. Here, we show that human adipocyte fatty acid-binding protein 4 (FABP4) can bind a diverse array of PFAS, including next-generation replacements for legacy chemicals and longer-chain perfluorocarboxylic acids. Shorter-chain PFAS, although weaker binders, still displayed measurable affinities, surpassing those of their nonfluorinated analogs. We determined crystal structures of FABP4 bound to perfluorooctanoic acid (PFOA), perfluorodecanoic acid (PFDA), and perfluorohexadecanoic acid (PFHxDA), revealing three distinct binding modes. Notably, PFOA binds in two separate sites, and two distinct conformations define single-ligand binding of PFDA and PFHxDA. These arrangements enhance hydrophobic interactions within the binding cavity and likely explain the low micromolar dissociation constants observed in fluorescence competition assays. Our findings underscore the critical roles of chain length, headgroup functionality, and protein conformation in PFAS-FABP4 interactions. Given the emerging implications of the role of FABP4 in endocrine function, even subtle PFAS-induced perturbations could affect metabolic regulation and disease risk. Overall, this work highlights the value of direct structural and biochemical insights into PFAS-FABP4 interactions and paves the way for future research on PFAS transport and toxicological outcomes.

Indexed as

FABP4Fatty acid binding protein 4fluorinated ligandsper- and polyfluoroalkyl substancesPFASprotein structureX-ray crystallography

Identifiers

PMID40575325
PMCPMC12188406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.